Amend CSSB 173 (Senate Committee Printing) as follows:
(1) In SECTION 2 of the bill, in added Section 481.1031(a), Health and Safety Code (page 1, lines 44 through 57), strike Subdivisions (1), (2), and (3) and substitute the following:
(1) "Core component" is one of the following: azaindole, benzimidazole, benzothiazole, carbazole, imidazole, indane, indazole, indene, indole, pyrazole, pyrazolopyridine, pyridine, or pyrrole.
(2) "Group A component" is one of the following: adamantane, benzene, cycloalkylmethyl, isoquinoline, methylpiperazine, naphthalene, phenyl, quinoline, tetrahydronaphthalene, tetramethylcyclopropane, amino oxobutane, amino dimethyl oxobutane, amino phenyl oxopropane, methyl methoxy oxobutane, methoxy dimethyl oxobutane, methoxy phenyl oxopropane, or an amino acid.
(3) "Link component" is one of the following functional groups: carboxamide, carboxylate, hydrazide, methanone (ketone), ethanone, methanediyl (methylene bridge), or methine.
(2) In SECTION 2 of the bill, in added Section 481.1031(b)(5), Health and Safety Code (page 5, line 5), strike "Naphtoylindane" and substitute "Naphthoylindane".